Literature DB >> 20667443

An assay for functional dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) inhibitors of human dendritic cell adhesion.

Natasa Obermajer1, Urban Svajger, Matjaz Jeras, Sara Sattin, Anna Bernardi, Marko Anderluh.   

Abstract

We report a new dendritic cell adhesion assay, using either immature or mature dendritic cells, for identifying functional dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) inhibitors. Because immature dendritic cells are responsible for pathogen binding and invasion, this in vitro assay provides an important link between in vitro results and pathogen-based in vivo assays. Furthermore, this assay does not require laborious expression, refolding, and purification of DC-SIGN carbohydrate recognition domain or extracellular domain as receptor-based assays. The assay power evaluated with Z and Z' parameters enables screening of compound libraries and determination of IC(50) values in the first stage of DC-SIGN inhibitor development. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667443     DOI: 10.1016/j.ab.2010.07.018

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Possible involvement of CD10 in the development of endometriosis due to its inhibitory effects on CD44-dependent cell adhesion.

Authors:  Akira Iwase; Tomomi Kotani; Maki Goto; Hiroharu Kobayashi; Sachiko Takikawa; Tatsuo Nakahara; Tomoko Nakamura; Mika Kondo; Yoshinari Nagatomo; Fumitaka Kikkawa
Journal:  Reprod Sci       Date:  2013-05-07       Impact factor: 3.060

2.  Quinoxalinone Inhibitors of the Lectin DC-SIGN.

Authors:  Shane L Mangold; Lynne R Prost; Laura L Kiessling
Journal:  Chem Sci       Date:  2011-11-24       Impact factor: 9.825

3.  Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists.

Authors:  Nataša Obermajer; Sara Sattin; Cinzia Colombo; Michela Bruno; Urban Svajger; Marko Anderluh; Anna Bernardi
Journal:  Mol Divers       Date:  2010-11-14       Impact factor: 2.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.